Walleye Capital’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$7.16M Buy
2024
Q2
$3.55M Buy
2024
Q1
$4.23M Buy
2022
Q2
Sell
2022
Q1
$312K Buy